Colon cancer​ patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind ...

A new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn't ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

The first half of this year has been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...

Oncology biosimilars significantly reduce financial toxicity in cancer care, as highlighted in 2 abstracts presented at the ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...